Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Dermatology and Therapy
Published in: Dermatology and Therapy 12/2023

Open Access 30-10-2023 | Acne Inversa | Review

Dietary Factors and Hidradenitis Suppurativa

Authors: Alan S. Shen, Jessica S. Johnson, Michelle Lynn Kerns

Published in: Dermatology and Therapy | Issue 12/2023

Login to get access

Abstract

Hidradenitis suppurativa (HS) is a debilitating chronic inflammatory skin condition affecting hair follicles in flexural sites. Obesity is considered to be a risk factor for HS occurrence and thought to be associated with increased severity of HS symptoms. Here, we review the literature examining the impact of dietary factors on HS. Moreover, we propose potential mechanistic links between dietary factors and HS pathogenesis, incorporating evidence from both clinical and basic science studies.
Literature
1.
Weigelt MA, Milrad SF, Kirby JRS, Lev-Tov H. Psychosocial impact of hidradenitis suppurativa: a practical guide for clinicians. J Dermatolog Treat. 2022;33(4):1861–8.PubMedCrossRef
2.
3.
Nguyen TV, Damiani G, Orenstein LV, Hamzavi I, Jemec GB. Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life. J Eur Acad Dermatol Venereol. 2021;35(1):50–61.PubMedCrossRef
4.
Garg A, Kirby JS, Lavian J, Lin G, Strunk A. Sex- and age-adjusted population analysis of prevalence estimates for hidradenitis suppurativa in the United States. JAMA Dermatol. 2017;153(8):760–4.PubMedPubMedCentralCrossRef
5.
6.
7.
Mintoff D, Benhadou F, Pace NP, Frew JW. Metabolic syndrome and hidradenitis suppurativa: epidemiological, molecular, and therapeutic aspects. Int J Dermatol. 2022;61(10):1175–86.PubMedCrossRef
8.
Ergun T. Hidradenitis suppurativa and the metabolic syndrome. Clin Dermatol. 2018;36(1):41–7.CrossRef
9.
Mintoff D, Agius R, Fava S, Pace NP. Investigating adiposity-related metabolic health phenotypes in patients with hidradenitis suppurativa: a cross-sectional study. J Clin Med. 2023;12(14):4847.PubMedPubMedCentralCrossRef
10.
Casas R, Urpi-Sardà M, Sacanella E, et al. Anti-inflammatory effects of the Mediterranean diet in the early and late stages of atheroma plaque development. Mediators Inflamm. 2017;2017:3674390.PubMedCentralCrossRef
11.
Barrea L, Fabbrocini G, Annunziata G, et al. Role of nutrition and adherence to the Mediterranean diet in the multidisciplinary approach of hidradenitis suppurativa: evaluation of nutritional status and its association with severity of disease. Nutrients. 2018;11(1):57.PubMedPubMedCentralCrossRef
12.
Lorite-Fuentes I, Montero-Vilchez T, Arias-Santiago S, Molina-Leyva A. Potential benefits of the Mediterranean diet and physical activity in patients with hidradenitis suppurativa: a cross-sectional study in a Spanish population. Nutrients. 2022;14(3):551.PubMedCrossRef
13.
Fernandez JM, Marr KD, Hendricks AJ, et al. Alleviating and exacerbating foods in hidradenitis suppurativa. Dermatol Ther. 2020;33(6): e14246.CrossRef
14.
15.
Kurzen H, Kurzen M. Secondary prevention of hidradenitis suppurativa. Dermatol Rep. 2019;11(2):8243.CrossRef
16.
Danby FW. Diet in the prevention of hidradenitis suppurativa (acne inversa). J Am Acad Dermatol. 2015;73(5, Supplement 1):S52–4.CrossRef
17.
Maarouf M, Platto JF, Shi VY. The role of nutrition in inflammatory pilosebaceous disorders: implication of the skin-gut axis. Australas J Dermatol. 2019;60(2):e90–8.PubMedCrossRef
18.
Monfrecola G, Balato A, Caiazzo G, et al. Mammalian target of rapamycin, insulin resistance and hidradenitis suppurativa: a possible metabolic loop. J Eur Acad Dermatol Venereol. 2016;30(9):1631–3.PubMedCrossRef
19.
Ren W, Yin J, Duan J, et al. mTORC1 signaling and IL-17 expression: defining pathways and possible therapeutic targets. Eur J Immunol. 2016;46(2):291–9.PubMedCrossRef
20.
Jennings L, Hambly R, Hughes R, Moriarty B, Kirby B. Metformin use in hidradenitis suppurativa. J Dermatolog Treat. 2020;31(3):261–3.PubMedCrossRef
21.
Amin S, Lux A, O’Callaghan F. The journey of metformin from glycaemic control to mTOR inhibition and the suppression of tumour growth. Br J Clin Pharmacol. 2019;85(1):37–46.PubMedCrossRef
22.
Molnar J, Mallonee CJ, Stanisic D, et al. Hidradenitis suppurativa and 1-carbon metabolism: role of gut microbiome, matrix metalloproteinases, and hyperhomocysteinemia. Front Immunol. 2020;11:1730.PubMedCentralCrossRef
23.
Nakamizo S, Honda T, Sato T, et al. High-fat diet induces a predisposition to follicular hyperkeratosis and neutrophilic folliculitis in mice. J Allergy Clin Immunol. 2021;148(2):473-485.e10.CrossRef
24.
Cannistrà C, Finocchi V, Trivisonno A, Tambasco D. New perspectives in the treatment of hidradenitis suppurativa: surgery and brewer’s yeast-exclusion diet. Surgery. 2013;154(5):1126–30.PubMedCrossRef
25.
Aboud C, Zamaria N, Cannistrà C. Treatment of hidradenitis suppurativa: surgery and yeast (Saccharomyces cerevisiae)-exclusion diet. Results after 6 years. Surgery. 2020;167(6):1012–5.PubMedCrossRef
26.
Assan F, Gottlieb J, Tubach F, et al. Anti-Saccharomyces cerevisiae IgG and IgA antibodies are associated with systemic inflammation and advanced disease in hidradenitis suppurativa. J Allergy Clin Immunol. 2020;146(2):452-455.e5.PubMedCrossRef
27.
Brocard A, Knol A-C, Khammari A, Dréno B. Hidradenitis suppurativa and zinc: a new therapeutic approach. A pilot study. Dermatology. 2007;214(4):325–7.PubMedCrossRef
28.
Hessam S, Sand M, Meier NM, Gambichler T, Scholl L, Bechara FG. Combination of oral zinc gluconate and topical triclosan: an anti-inflammatory treatment modality for initial hidradenitis suppurativa. J Dermatol Sci. 2016;84(2):197–202.PubMedCrossRef
29.
Poveda I, Vilarrasa E, Martorell A, et al. Serum zinc levels in hidradenitis suppurativa: a case-control study. Am J Clin Dermatol. 2018;19(5):771–7.PubMedCrossRef
30.
Molinelli E, Brisigotti V, Campanati A, et al. Efficacy of oral zinc and nicotinamide as maintenance therapy for mild/moderate hidradenitis suppurativa: a controlled retrospective clinical study. J Am Acad Dermatol. 2020;83(2):665–7.CrossRef
31.
32.
Rosenkranz E, Maywald M, Hilgers R-D, et al. Induction of regulatory T cells in Th1-/Th17-driven experimental autoimmune encephalomyelitis by zinc administration. J Nutr Biochem. 2016;29:116–23.PubMedCrossRef
33.
Rosenkranz E, Metz CHD, Maywald M, et al. Zinc supplementation induces regulatory T cells by inhibition of Sirt-1 deacetylase in mixed lymphocyte cultures. Mol Nutr Food Res. 2016;60(3):661–71.PubMedCrossRef
34.
George MM, Vignesh KS, Landero Figueroa JA, Caruso JA, Deepe GS. Zinc induces dendritic cell tolerogenic phenotype and skews regulatory T cell—Th17 balance. J Immunol. 2016;197(5):1864–76.PubMedCrossRef
35.
Kelly G, Sweeney CM, Fitzgerald R, et al. Vitamin D status in hidradenitis suppurativa. Br J Dermatol. 2014;170(6):1379–80.CrossRef
36.
Guillet A, Brocard A, Bach Ngohou K, et al. Verneuil’s disease, innate immunity and vitamin D: a pilot study. J Eur Acad Dermatol Venereol. 2015;29(7):1347–53.PubMedCrossRef
37.
Seetan K, Eldos B, Saraireh M, et al. Prevalence of low vitamin D levels in patients with Hidradenitis suppurativa in Jordan: a comparative cross-sectional study. PLoS One. 2022;17(3): e0265672.PubMedCrossRef
38.
Brandao L, Moura R, Tricarico PM, et al. Altered keratinization and vitamin D metabolism may be key pathogenetic pathways in syndromic hidradenitis suppurativa: a novel whole exome sequencing approach. J Dermatol Sci. 2020;99(1):17–22.PubMedCrossRef
39.
Umar M, Sastry KS, Al Ali F, Al-Khulaifi M, Wang E, Chouchane AI. Vitamin D and the pathophysiology of inflammatory skin diseases. Skin Pharmacol Physiol. 2018;31(2):74–86.PubMedCrossRef
40.
Gorman S, Geldenhuys S, Judge M, Weeden CE, Waithman J, Hart PH. Dietary vitamin D increases percentages and function of regulatory T cells in the skin-draining lymph nodes and suppresses dermal inflammation. J Immunol Res. 2016;2016:1426503.PubMedPubMedCentralCrossRef
41.
Yamanaka K, Dimitroff CJ, Fuhlbrigge RC, et al. Vitamins A and D are potent inhibitors of cutaneous lymphocyte-associated antigen expression. J Allergy Clin Immunol. 2008;121(1):148-157.e3.CrossRef
42.
Moltrasio C, Tricarico PM, Genovese G, Gratton R, Marzano AV, Crovella S. 25-Hydroxyvitamin D serum levels inversely correlate to disease severity and serum C-reactive protein levels in patients with hidradenitis suppurativa. J Dermatol. 2021;48(5):715–7.PubMedCrossRef
43.
Marasca C, Donnarumma M, Annunziata MC, Fabbrocini G. Homocysteine plasma levels in patients affected by hidradenitis suppurativa: an Italian experience. Clin Exp Dermatol. 2019;44(3):e28–9.PubMedCrossRef
44.
Mortimore M, Florin THJ. A role for B12 in inflammatory bowel disease patients with suppurative dermatoses? An experience with high dose vitamin B12 therapy. J Crohns Colitis. 2010;4(4):466–70.PubMedCrossRef
45.
Lazzerini PE, Capecchi PL, Selvi E, et al. Hyperhomocysteinemia, inflammation and autoimmunity. Autoimmun Rev. 2007;6(7):503–9.PubMedCrossRef
46.
Au-Yeung KKW, Woo CWH, Sung FL, Yip JCW, Siow YL, Karmin O. Hyperhomocysteinemia activates nuclear factor-κB in endothelial cells via oxidative stress. Circ Res. 2004;94(1):28–36.PubMedCrossRef
47.
Damiani G, Mahroum N, Pigatto PDM, et al. The safety and impact of a model of intermittent, time-restricted circadian fasting (“Ramadan Fasting”) on hidradenitis suppurativa: insights from a multicenter, observational, cross-over, pilot, exploratory study. Nutrients. 2019;11(8):1781.PubMedPubMedCentralCrossRef
Metadata
Title
Dietary Factors and Hidradenitis Suppurativa
Authors
Alan S. Shen
Jessica S. Johnson
Michelle Lynn Kerns
Publication date
30-10-2023
Publisher
Springer Healthcare
Published in
Dermatology and Therapy / Issue 12/2023
Print ISSN: 2193-8210
Electronic ISSN: 2190-9172
DOI
https://doi.org/10.1007/s13555-023-01056-1

Other articles of this Issue 12/2023

Dermatology and Therapy 12/2023 Go to the issue

Review

The Diagnostic Workup, Screening, and Treatment Approaches for Patients with Delusional Infestation

Original Research

Efficacy of Avène Hydrotherapy on Chronic Pruritus in Patients with Plaque Psoriasis

Original Research

Health-Related Quality of Life with Pembrolizumab in Patients with Locally Advanced or Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: KEYNOTE-629

Brief Report

Real-Life Utility of Basophil Activation Test in the Diagnosis of Immediate Hypersensitivity Drug Reactions

Original Research

The Benefits of a Multimechanistic Antiaging Skin Technology

Original Research

Clinical Benefits of Baricitinib Therapy According to Scalp Hair Regrowth in Patients with Severe Alopecia Areata
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits